The Cancer History Project Guest Editor Robert Winn focused on the legacy of LaSalle Leffall, a Howard University surgical oncologist. He and John H. Stewart, director of Louisiana State University-Louisiana Children’s Medical Center Health Cancer Center spoke with Wayne A.I. Frederick, president of Howard University.
As we begin our coverage of Black History Month, we invite you to revisit our coverage from last year.
The Omicron variant of SARS-CoV-2 is a powerful reminder that the COVID-19 pandemic, now entering its third year, will continue to have personal and public health impacts. This may be especially true for those individuals who unfortunately missed or delayed cancer screening or treatment as a result of the pandemic.
St. Jude Children’s Research Hospital is taking on a major global health challenge—the murky quagmire of drug shortages—by partnering with the World Health Organization to prove that practical solutions are within reach.
St. Jude Children’s Research Hospital’s new $200-million Global Platform for Access to Childhood Cancer Medicines—a partnership with the World Health Organization—can be traced back to a critique from a visiting reviewer.
Many global health professionals have dreamed about solving drug shortages, and St. Jude Children’s Research Hospital is taking the first steps toward eliminating the problem, said Carlos Rodriguez-Galindo, director of St. Jude Global.
NCI has issued a Request for Information seeking input from developers of multi-cancer early detection liquid biopsy tests, with the goal of launching an NCI-sponsored randomized controlled screening clinical trial of these tools.
Racial and ethnic inequities are pervasive in clinical research—from the systemic factors that deter underrepresented populations from pursuing careers in science and medicine, to the discrimination, lack of support, and other hardships faced by those who do enter the biomedical profession.
“I think we have to be thoughtful about our expectations and not overpromise because the next steps may take longer for us than, say, the rapid development of anti–PD-1 therapies,” Jedd D. Wolchok said.
The acquisition of Cancer Treatment Centers of America will allow City of Hope to build a national network of cancer centers that is fundamentally different from those of other cancer centers.
